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Summary: In this study we have investigated five quantitative and three semi-quantitative rheumatoid factor
assays and the Rose-Waaler assay in 120 patients suffering from rheumatoid arthritis and in 76 with other
systemic diseases. All tests measure the IgM anti-IgG antibodies.
The correlations between the quantitative tests were all higher than 0.86 and much better than between the
quantitative and semi-quantitative tests and the semi-quantitative tests themselves (r between 0.22 and 0.85).
The within run and between run precision studies for the quantitative tests showed CV values lower than
16%.
In spite of the standardisation on the WHO and the Center of Disease Control Reference Preparation we
found important differences in patient results.
From an analytical point of view, the quantitative assays for rheumatoid factors show certain advantages
over the traditional haemagglutination tests.
Introduction
The measurement of rheumatoid factors in patients
with rheumatoid arthritis can provide information
about the diagnosis, prognosis and response to ther-
apy of the disease.
The rheumatoid factors are äütoantibodies against
the Fc fragment of the immunoglobulin G (IgG).
The antibodies measured in most laboratory assays
are of the IgM class, although they also appear in
other immunoglobulin classes (1).
The classical method for the determination of the
rheumatoid factors is the Rose-Waaler haemagglutin-
ation assay (2, 3).
This semi-quantitative dilution assay is difficult to
standardize, has a poor reproducibility and is rather
laborious.
To overcome some of these problems, we have used
for several years a modified Rose-Waaler assay in our
laboratories (4).
Recently several new automated analysers and tech-
niques for the quantitative determination of rheu-
matoid factors have become available.
They consist of radio-(5) and enzyme-immunoassays
(6), or nephelometric (7) and turbidimetric methods
(8,9).
In this study we describe an evaluation of five quan-
titative rheumatoid factor assays, one semi-quantita-
tive latex test and two modified Rose-Waaler assays.
These tests all measure the IgM anti-IgG antibodies.
The results are compared with those determined with
the traditional Rose-Waaler method.
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Materials and Methods
(Semi-)quant i ta t ive rheumatoid factor tests
The classical Rose-Waaler assay was carried out by the Central
Laboratory of the Blood Transfusion Service of the Dutch Red
Cross, at Amsterdam. All other tests were carried out by us
according to the protocols of the manufacturers.
The tests are:
Quantitative assays (A — E):
A: Beckman Array (Beckman Instruments, Inc, Brea, CA,
USA).
B: Beckman ICS (Beckman Instruments, Inc, Brea, CA, USA).
C: Behring BNA (Behringwerke AG, Marburg, Federal Re-
public of Germany).
D: Diesse TasoMatic (Diesse, Monteriggioni (Si), Italy).
E: Hoffmann-LaRoche Cobas-Bio (Hoffmann-LaRoche,
Basle, Switzerland)/Orion (Orion Diagnostica, Espoo, Fin-
land).
Semi-quantitative assays (F — I):
F: Cellognost-RF-micro (Behringwerke AG, Marburg, Federal
Republic of Germany).
G: RAHA (Fujirebio Inc, Tokyo, Japan).
H: RF-tube test (HofTman-LaRoche, Basle, Switzerland).
I: Rose-Waaler.
The main characteristics of the nine rheumatoid factor tests
and the instruments involved are shown in table 1. We have
classified the Diesse TasoMatic (D) under the quantitative
methods although this instrument gives its results in a stepwise
manner: < 50, 50, 60, 70 to 200 by steps of 10 lU/ml, 225,
250, 300 and > 350 lU/ml.
Patient samples
The samples were obtained from patients visiting the rheuma-
tology and pulmonary departments of our hospitals (tab. 2).
The diagnosis, rheumatoid arthritis, was obtained by the rheti-
matologists using the American Rheumatism Association cri-
teria (10). . f
The blood samples were collected by venepuncture in vacutainer
SST tubes (Becton and Dickinson, Rutherford, NJ, USA) and
allowed to clot. The serum was removed and, in order to avoid
repeated freezing and thawing, divided into aliquots and stored
at —20 °C until assay.
All samples were inactivated by incubating for 30 minutes at
56 °C, except for the method of Diesse Taso-Matic (D) and the
RF-tube test (H).
For both Beckman methods, Array (A) and ICS (B), the in-
activated samples were centrifuged at 8000 g for five minutes.
Standardisation and controls
For the titration methods the "Relares serum" (the Dutch
reference serum preparation for rheumatoid factors related to
the "international reference preparation of rheumatoid arthritis
serum of the WHO") (11) was used as a standard to convert
titres to IU/ml.
For the preparation of this "Relares serum", plasma was first
obtained by plasmapheresis from 20 patients with rheumatoid
arthritis. Serum was then prepared by recalcification and di-
Tab. 1. Main characteristics of the nine (semi-)quantitative tests used for the rheumatoid factor assays.
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Tab. 2. The origin of the 196 patient samples.
Clinical diagnosis Number
1. Classical rheumatoid arthritis














vided into ampoules and lyophilized. After reconstitution with
1 ml distilled water the values were determined by Relares
(Reference Laboratory Reuma-serology) by comparison with
the WHO reference serum of 100 ITJ/ml. The "Relares serum"
gave a value of 400 lU/ml in the Rose-Waaler test and 200 IU/
ml in the Latex-tests.
For the five quantitative methods the standard(s) provided with
the kits were used. The standard used for the Behring BNA
(C), Diesse TasoMatic (D) and Cobas-Bio/Orion (E) is related
to the WHO reference serum. For Beckman Array (A) and
Beckman ICS (B) the standard is related to the "American
Center of Disease Control National Reference Preparation for
rheumatoid factors" (12).
In all semi-quantitative and quantitative assays we used the
"Behring Rheumatoid Reference Serum" as a control.
This reference serum consists of a pool of human sera with a
high concentration of rheumatoid factors. The reference serum
is calibrated according to the Rose-Waaler test as recommended
by the WHO (11) by comparison with the WHO International
Reference Preparation.
In the quantitative tests we used also the "Relares serum" as a
control serum.
Statistical analysis
Orthogonal regression analysis was performed according to the
method of Deming as discussed by Cornbleet et al. (13).
The outlayers test described herein was only used in the cor-
relation analyses of the five quantitative tests (A—E). Outlayers
were defined as values outside four times the standard error of
estimate (13).
Precision between and within runs
Precision studies were performed with the following five quan-
titative methods: Beckman Array (A), Beckman ICS (B), Behr-
ing BNA (C), Diesse TasoMatic (D) and Cobas-Bio/Orion (E).
The within fun precision analyses were carried out in pooled
patient sera. Each serum was estimated 8 to 12 times. The sera
were choosen so that the concentrations of rheumatoid factors
were spread over the whole measuring range of the instruments.
The value of 499 lU/ml by the Diesse TasoMatic method (D)
however was obtained with diluted (9 g/1 NaCl) serum.
For the between run precision analyses we used two to four
samples in every run. These samples were Behring Rheumatoid
Reference Serum for rheumatoid factors, Relares serum, Pooled
Patient Serum, Standard 100 IU/ml of Diesse and Calibration
Serum of Beckman.
Correlation studies
The titres of the dilution methods were converted to IU/ml
before the regression analyses were performed.
For the correlation studies we used the results of all 196 pa-
tients, unless one or both values were zero, below the lowest
standard or below the detection limit of the method.
Sensitivity, specificity and predict ive va lue (14)
Sensitivity indicates the probability of positive test restults when
the disease is present (positivity in disease).
It may be expressed by the following relationship:
number of RA-paticnts with positive test
total number of RA-patients
Sensitivity =
Specificity indicates the probability of negative test results when
the disease is not present (negativity in health).
It may be expressed by the following relationship:
Specificity
_ number of patients without RA with negative test
total number of patients without RA
The predictive value of a positive test is expressed by:
number of RA-patients with positive test
total number of positive tests
The predictive value of negative test is expressed by:
number of patients without RA with negative test
total number of negative tests
The predictive value of a positive (negative) test indicates the
probability that the disease (RA, rheumatoid arthritis) is present
(absent) when the test is positive (negative).
Results and Discussion
Precision within and between runs
The within and between run precision data are given
in table 3.
The within run precision was good (< 4%) for the
Beckman Array (A) method, the Behring BNA (B)
method (except for the value 575 IU/ml) and the
Cobas-Bio/Örion (E) method [except near its detec-
tion limit of 15 IU/ml (CV = 16% for the value of
19 IU/ml)].
The coefficient of variation of 8.4% for the Behring
BNA (B) method was obtained in a pooled patient
serum with a mean value of 575 IU/ml. This value is
near the beginning of the range requiring dilution of
the sample.
The ten results for this pooled serum are shown in
table 4. The mean value for the four undiluted samples
was 517 IU/ml and for the six automatically diluted
samples 614 IU/ml. This difference in mean values
might be explained by the use of different parts of
the calibration curve.
For the Diesse TasoMatic (D) the within run precision
appeared to be satisfactory with a CV < 11%, taking
into account the stepwise presentation of the results.
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Tab. 3. Precision between and within run (CV%) of the Beckman Array (A), Beckman ICS (B), Behring BNA (C), Cobas-Bio/
Orion (D) and the Diesse TasoMatic (E).
All values are in lU/ml.
1 = Behring Rheumatoid Reference Serum. 2 = Relares Serum. 3 = For the Beckman Array (A) the Calibrator, for
the Behring BNA (C) pooled serum and for the Diesse TasoMatic (E) the standard 100 IU/1.
































































































































































Tab. 4. Results of the within-run precision study of a pooled
patient serum with a value around the automatic dilu-







































The between run precision for the Beckman Array
(A) and the Behring BNA (C) was good (< 9%), for
the other quantitative methods acceptable (< 17%).
The manual titre methods gave a maximal difference
of only one dilution step.
Correlation studies
The correlations between the quantitative and semi-
quantitative methods and between the semi-quanti-
tative methods themselves are shown in table 5.
It can be seen that the coefficients of correlation (r)
between the quantitative methods A^E and the semi-
quantitative tests F and I are all below of equal to
0.53. Between the quantitative methods A—E and the
RAHA (G) and RF-tube test (H) a higher correlation
was observed, i. e. r = 0.65 to r = 0.85.
The coefficients of correlation between each of the
semi-quantitative methods (F, G, H and I) were all
less than 0.65.
In table 6 the coefficients of correlation between each
of the five quantitative tests (A, B, C, D and E) are
shown, ranging from r = 0.86 to r = 0.99.
In figures 1 and 2 the serum values obtained with the
five quantitative methods A — E are plotted against
each other.
The correlation between the quantitative tests them-
selves is much stronger then between the semi-quari-
titative and quantitative tests or between the semi-
quantitative tests themselves.
This less satisfactory coefficient of correlation can be
partly explained by the use of titres. In the'conversion
of titres to numerical values (lU/ml) a difference of
only one dilution step causes the doubling or halving
of the value in lU/ml (15).
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Tab. 5. Dewing debiased regression analyses between the quan-
titative (A—E) and the semi-quantitative methods
(F—I) and the semi-quantitative tests (F — I) them-
selves.
No correction for outlayers was applied here,
n = number of patients; r = coefficient of correlation;
Tab. 6. Dewing debiased regression analyses between the five
quantitative methods (A — E) without outlayers.
n = number of patients; r = coefficient of correlation;
b = intercept; a = slope; y = b -I- ax.
(Vertical method = x, horizontal method = y).
e = number of outlayers.
ο — intercept; a — siope; y — σ -t- ax.






















































































































































































Method Beckman Behring Diesse Cobas-
r/^Q D XT Α ΤΓ«·»ί»Λ Di,»./ICo -blNA laSO- BlO/
(B) (C) Matic Orion
(D) (E)
Beckman η 59 68 56 65
Array r 0.99 0.95 0.86 0.98
(A) b 38 46 86 40
a 0.96 0.50 0.20 0.34
e 17 6 1 9
Beckman n - 84 56 77
ICS r - 0.98 0.89 0.98
(B) b 26 52 -7
a - 0.75 0.30 0.56
e - 15 4 12
Behring η — — 54 80
BNA r - - 0.97 0.98
(C) b _ _ 9 7
a - - 0.58 0.74
e — — 6 8
Diesse n — — — 53
TasoMatic r — — — 0.98
(D) b 2
a — - - 1.20
e — — — 5
For the Cellognost-RF-micro (F), a titre of 1 : 80
corresponded to 400 lU/ml, for the RAHA (G) a titre
of 1 : 2560 represented 300 lU/ml, while for the RF-
tube-test (H) a titre of 1 : 160 represented a value of
200 lU/ml. For the Rose-Waaler method (I) the Re-
lares serum was used as a standard (400 lU/ml) in
every run to convert the titres into lU/ml.
In every run also the Behring Rheumatoid Reference
serum was assayed. For the Cellognost-RF-Micro (F)
a value of 200 lU/ml was found, for the RAHA (G)
50 lU/ml and for the RF-tube test (H) 75 lU/ml.
For the Rose-Waaler method this Behring Rheuma-
Standardisation and controls
Semi-quantitative methods
In order to convert titres to Ill/ml for each method
in every run the Relares serum was assayed. After all
assays were complete, the mean titre of the Relares
serum was compared with its target value in lU/ml
(16).
toid Reference Serum was assayed twice at 100 IU/
ml.
Quantitative methods
Data were first obtained by using the standards sup-
plied with the kits. In addition the Relares Serum and
the Behring Rheumatoid Reference Serum were ana-
lysed in every run. Table 7 shows the mean values
and standard deviations for these two sera.
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0 600 1200 1800 2400 & 0 600 1200 1800 2400
Rheumatoid factors (Beckman Array) L103IU/U Rheumatoid factors (Beckman ICS) C103IU/U
Fig. 1. Graphs showing the correlations between the quantitative rheumatoid factor assays.
All values are in IU/ml. α = outlayer in Deming debiased orthogonal regression analyses.
It should be mentioned that the standards used in
methods A and Β were related to the reference prep-
aration of the Center of Disease Control, but for the
other methods (C, D and E) to that of the WHO.
The value of the Center of Disease Control Reference
Preparation is 2.3 times the value of the WHO (17).
Therefore in table 7, the values of "Relares" and
"Behring" sera for methods A and B are also given
in WHO units.
The values for the Relares serum obtained with the
quantitative methods, all related to the WHO units,
are now between 208 and 280 IU/ml and the values
for the Behring Rheumatoid Reference Serum be-
tween 62 and 118 IU/ml.
In spite of standardisation using the well defined
WHO Reference Preparation for the quantitative tests
C, D and E and using the Center of Disease Control
Reference Preparation for the methods A and B, there
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Rheumatoid factors (Behring B N A ) L103IU/U
52400
0 600 1200 1800 2400
Rheumatoid factors (Diesse TasoMaticJC103IU/U
Fig. 2. Graphs showing the correlations between the quantitative rheumatoid factor assays.
All values are in IU/ml. α = outlayer in Deming debiased orthogonal regression analyses.
Tab. 7. Values of the Relares serum and Behring Rheumatoid
Reference Serum related to the WHO units for methods
C, D and E and to the Center of Disease Control units
for methods A and B.
The values in the second column in brackets by methods
A and B are obtained after conversion of the Center of
Disease Control units to WHO units. (Here we used:












































was a large systematic difference in the actual values
found. These differences were observed for the patient
sera (tab. 6, figs. 1 and 2) as well as for the Relares
Serum and the Behring Rheumatoid Reference Serum
(tab. 7).
This discrepancy in bias might be explained by the
variability of the IgG antibodies used in the various
kits. Another explanation could be the difference in
the origin of the rheumatoid factor preparations used
as standards in the kits, since these rheumatoid factors
are a group of diverse globulins.
We also investigated the number of positive patient
sera which exceeded the measuring ranges of the kits.
A large difference was found between the methods
used; see table 8.
Sera showing values above the upper limit of the
measuring range were diluted 1:6. Further dilution
was necessary for sixteen of the sera, but only for the
Cobas-Bio/Orion method.
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Tab. 8. Proportions of patient sera reanalysed because values























In table 9 the sensitivity, specificity, the positive and
the negative predictive values of the methods used
(A —I) are shown.
With regard to these calculations we divided the pa-
tients into two groups. The first group consisted of
the patients suffering from classical rheumatoid ar^
thritis and definitive rheumatoid arthritis, i.e. num-
bers one and two( from table 2. The second group
consisted of the patients suffering from other diseases,
such as reactive arthritis, sarcoidosis, ankylosing
spondylitis, Morbus Reiter and systemic lupus ery-
thematosus, i.e. numbers three to seven from table 2.
Table 9 shows that of the semi-quantitative methods
(F-I), the RF-tube test (H) gives the best results.
The quantitative methods (A — E) do not show iden-
tical results.
The clinical usefulness of the quantitative tests seems
identical to, or better than the traditional Rose- Waaler
method (I) or the other semi-quantitative tests (F, G
and H); see table 9. However, from the analytical
point of view we recommend the use of one of the
quantitative tests for the determination of the rheu-
matoid factors, with patient results expressed in IU/
ml.
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Tab. 9. Sensitivity, specificity and predictive values of positive and negative results of the various methods in "RA" and "no-RA"
patients. See text for further explanation.






























































































































J. Clin. Chem. Clin. Biochem. / Vol. 26,1988 / No. 12
Jaspers et al.: Nine rheumatoid factor assays compared 871
References
1. Egeland, T. & Munthe, E. (1983) Clin. Rheum. Dis. 9,
135-160.
2. Waaler, E. (1940) Acta Pathol. Microbiol. Scand. 17, 172-
188.
3. Rose, H. M:, Ragan, C., Pearch, E. & Olmstead Lipman,
E. (1948) Proc. Soc. Exp. Biol. Med. 68, 1-6.
4. Fleuren, H. L. J. M., Van Ocrs, R. J. M. & Jaspers, J. P.
M. M. (1983) Tijdschrift NVKC 4, 126-130.
5. Koopman, W. J. & Schrohenloker, R. E. (1980) Arthritis
Rheum. 23, 302-308.
6. Bampton, J. L. M., Cawston, T. E., Kyle, M. V. & Hazele-
man, B. L. (1985) Ann. Rheum. Dis. 44, 13-19.
7. Roberts-Thomson, P. J., McEvoy, R., Langhans, T. & Brad-
ley, J. (1985) Ann. Rheum. Dis. 44, 379-383.
8. Melanies, L. M., Ruutsalo, H. M. & Nissila, H. (1986)
Clin. Chem. 32, 1890-1984.
9. Borque, L., Yago, M., Mar, C. & Rodriques, C. (1986)
Clin. Chem. 32, 124-129.
10. Committee of the American Rheumation Association. Re-
vision of Diagnostic Criteria for Rheumatoid Arthritis
(1959) Arth. Reum. 2, 16-20.
11. Anderson, S. G., Bentzon, M. W., Houba, V. & Krag, P.
(1970) Bull. Wld. Hlth. Org. 42, 311-318.
12. Jones, W. L. & Wiggins, G. L. (1973) Am. J. Clin. Palhol.
60,703-706.
13. Cornbleet, P. J. & Gochman, V. (1979) Clin. Chem. 25,
432-438.
14. Griner, P. F. (1981) Ann. Int. Med. 94, 553-600.
15. Ritchie, R. P., Publication ICS-15, Beckman Instruments
International S. A., Switzerland.
16. Feltkamp, T. E. W. (1987) Report by Stichting Relares,
Amsterdam.
17. Feltkamp, T. E. W. (1986) Unpubl. data.




J, Clin. Chem. Clin. Biochem. / Vol. 26,1988 / No. 12

